NEWS

Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies We are glad to share with you our new white paper by Cromos™ Pharma’s VP, International Business & Operations Dr. Gearóid Tuohy regarding a new Clinical Trial Regulation (Regulation [EU] No 536/2014), scheduled for application this year, and its potential impact on the current imbalances in clinical trials. Please follow the link link to the

Cromos™ Pharma received regulatory approval for the first ever ophthalmological clinical trial in Georgia

Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials

DUBLIN, IRELAND–(Marketwired – October 24, 2016) – Cromos™ Pharma, a premier regional contract research organization announced today that Dr. Gearóid Tuohy has been appointed… Dr. Tuohy will join the company’s Dublin office and will bring strategic thinking and in-depth knowledge of the international clinical trials landscape to further expand Cromos™ Pharma’s operations amidst its growing geographic presence. “Cromos™ Pharma continues to grow at a fast pace and we are very excited to see Dr. Tuohy joining our team,” said

We at Cromos Pharma are always interested in what makes a sponsor choose a certain CRO In order to get a better understanding of this question we have conducted a survey where we asked industry professionals about their vision of a “perfect CRO”. Our team would like to express sincere gratitude to all the participants of the survey whose responses we greatly appreciate. Below you can find the top-line results of

Cromos Pharma published a new article on Feasibilty in Applied Clinical Trials Journal